18412280. FGFR3 BINDING MOLECULES AND METHODS OF USE THEREOF simplified abstract (Regeneron Pharmaceuticals, Inc.)
Contents
FGFR3 BINDING MOLECULES AND METHODS OF USE THEREOF
Organization Name
Regeneron Pharmaceuticals, Inc.
Inventor(s)
Yan Yang of Mamaroneck NY (US)
Naga Suhasini Avvaru of Briarcliff Manor NY (US)
Christopher Daly of New York NY (US)
Yang Shen of Scarsdale NY (US)
Chia-Yang Lin of Scarsdale NY (US)
FGFR3 BINDING MOLECULES AND METHODS OF USE THEREOF - A simplified explanation of the abstract
This abstract first appeared for US patent application 18412280 titled 'FGFR3 BINDING MOLECULES AND METHODS OF USE THEREOF
The abstract of the patent application discusses molecules that can bind to FGFR3 and their methods of use.
- Simplified Explanation:
The patent application focuses on molecules that have the ability to bind to FGFR3 and the ways in which they can be utilized.
- Key Features and Innovation:
- Molecules capable of binding to FGFR3 - Methods of using these molecules - Potential for targeted therapy in diseases involving FGFR3 dysregulation
- Potential Applications:
- Targeted therapy for diseases related to FGFR3 dysregulation - Precision medicine in treating specific conditions - Research and development in the field of FGFR3-related disorders
- Problems Solved:
- Addressing the need for targeted therapies in diseases involving FGFR3 - Providing a more precise approach to treatment based on molecular interactions - Advancing the understanding of FGFR3-related disorders
- Benefits:
- Improved efficacy in treating FGFR3-related diseases - Potential for personalized medicine approaches - Enhanced research opportunities in the field of FGFR3 biology
- Commercial Applications:
- Pharmaceutical companies developing targeted therapies - Biotechnology firms focusing on precision medicine - Research institutions studying FGFR3-related disorders
- Questions about FGFR3:
1. How do molecules binding to FGFR3 impact the treatment of related diseases? 2. What are the potential challenges in developing therapies targeting FGFR3 dysregulation?
- Frequently Updated Research:
- Stay informed about the latest advancements in FGFR3-targeted therapies - Explore ongoing studies on the molecular interactions of FGFR3-binding molecules
By providing a detailed overview of the molecules capable of binding to FGFR3 and their potential applications, this patent application opens up new avenues for targeted therapy and precision medicine in the treatment of FGFR3-related disorders.
Original Abstract Submitted
The present disclosure relates to molecules capable of binding to FGFR3 and methods of use thereof.
